Schizoaffective disorders:: Significant improvements following therapy change to risperidone long-acting injectable

被引：0
|
作者：
Mohl, A [1 ]
Westly, K [1 ]
Opjordsmoen, S [1 ]
Lex, A [1 ]
Bräunig, P [1 ]
机构：
[1] Psychiat Dienste Aargau EPD, Baden, Switzerland
来源：
EUROPEAN PSYCHIATRY | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [1] Results of direct switching to long-acting injectable risperidone in patients with schizoaffective disorders
    Mohl, A
    Westly, K
    Opjordsmoen, S
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 174 - 174
  • [2] Direct switch from atypical antipsychotics to long-acting injectable risperidone in schizophrenia and schizoaffective disorders
    Vauth, R
    Kusters, J
    Braendle, D
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 177 - 177
  • [3] Long-acting injectable risperidone
    Ehret, MJ
    Fuller, MA
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2122 - 2127
  • [4] Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone
    Permuy, RT
    Turner, MS
    Bouhours, P
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 175 - 175
  • [5] Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder
    Benabarre, A.
    Castro, P.
    Sanchez-Moreno, J.
    Martinez-Aran, A.
    Salamero, M.
    Murru, A.
    Franco, C.
    Vieta, E.
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 2009, 37 (03): : 143 - 147
  • [6] Cognitive improvements in patients with schizophrenia with risperidone long-acting injectable: Relationship to functioning?
    Pandina, G
    Bilder, R
    Harvey, P
    Lasser, RA
    Rodriguez, S
    Turkoz, I
    Gharabawi, G
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 500 - 500
  • [7] Open-label over effectiveness of long-acting risperidone as maintenance therapy of bipolar and schizoaffective disorders
    Castro-Loli, P.
    Benabarre, A.
    Martinez-Aran, A.
    Sanchez-Moreno, J.
    Salamero, M.
    Murru, A.
    Vieta, E.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S409 - S409
  • [8] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
  • [9] Long-acting risperidone in stable patients with schizoaffective disorder
    Mohl, A
    Westlye, K
    Opjordsmoen, S
    Lex, A
    Schreiner, A
    Benoit, M
    Bräunig, P
    Medori, R
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 22 - 31
  • [10] Attitudes toward long-acting injectable risperidone
    Han, C.
    Lee, B. H.
    Kim, Y. K.
    Choi, J. Y.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S266 - S266
12345